These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9480459)

  • 21. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical indications of different drugs for refractory arrhythmias (author's transl)].
    Leclercq JF; Coumel P
    Ther Umsch; 1982 Feb; 39(2):128-36. PubMed ID: 7071785
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heart arrhythmias in advanced age].
    Erdmann E
    Fortschr Med; 1991 Aug; 109(25):488-91. PubMed ID: 1937334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arrhythmia. Its management at the leading British center].
    Kułakowski P
    Kardiol Pol; 1992; 36(2):106-9. PubMed ID: 1583825
    [No Abstract]   [Full Text] [Related]  

  • 25. [New method for direct study of antiarrhythmic drugs in man. Electrophysiological effects and criteria for interpretation].
    Domenichelli B; Manzoli U; Schiavoni G; Feraco E
    Minerva Cardioangiol; 1974 Feb; 22(2):71-89. PubMed ID: 4820118
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of intravenous flecainide in the treatment of acute ventricular arrhythmia].
    Aliot E; Baille N; Zannad F; Gilgenkrantz JM
    Ann Cardiol Angeiol (Paris); 1983 Oct; 32(6):417-23. PubMed ID: 6666988
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part I.
    Singh BN; Cho YW; Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):139-51. PubMed ID: 7263102
    [No Abstract]   [Full Text] [Related]  

  • 28. [High resolution electrocardiography of P-wave signals in clinical cardiology].
    Kucinský R; Gonsorcík J; Franko J; Rajnic A; Olexa P
    Vnitr Lek; 2000 Feb; 46(2):130-5. PubMed ID: 11048540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration.
    Pandit SV; Noujaim SF; Jalife J
    Heart Rhythm; 2012 May; 9(5):e13-4; author reply e14. PubMed ID: 22426151
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the electrocardiogram of the rat caused by amiodarone].
    Mei V; Bruno C; Valora N; Martinoli L
    Boll Soc Ital Biol Sper; 1974 Feb; 50(4):177-81. PubMed ID: 4447712
    [No Abstract]   [Full Text] [Related]  

  • 31. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview.
    Dorian P; Newman D
    Europace; 2000 Oct; 2(4):277-85. PubMed ID: 11194593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Variability of the heart rate and QRS conformation of cardiograms in healthy probands and arrhythmia patients].
    Link A; Endt P; Gödde P; Oeff M; Trahms L
    Biomed Tech (Berl); 1997; 42 Suppl():63-4. PubMed ID: 9517048
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction and increase of cardiac arrhythmia by anti-arrhythmia agents].
    Hohnloser SH; Meinertz T; Mehender M; Geibel A; Just H
    Internist (Berl); 1988 May; 29(5):338-44. PubMed ID: 3042675
    [No Abstract]   [Full Text] [Related]  

  • 34. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization].
    Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F
    Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Banasiak W; Metner E
    Wiad Lek; 1987 Jan; 40(2):100-5. PubMed ID: 3296463
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
    von Philipsborn G
    Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
    Brachmann J
    Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nursing perspective of the invasive electrophysiologic approach to treatment of ventricular arrhythmias.
    Tyndall A
    Heart Lung; 1983 Nov; 12(6):620-9. PubMed ID: 6556176
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ; Kidwell GA
    Prog Cardiovasc Dis; 1993; 35(6):399-406. PubMed ID: 8497655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias.
    Takahara A; Sugiyama A; Hashimoto K
    Heart Vessels; 2004 Jan; 19(1):43-8. PubMed ID: 14685755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.